The VERTEX 80/80v optics design allows PEAK flexibility and PEAK instrument performance at the same time. The unique Bruker Optics DigiTect ™ technology ensures PEAK signal-to-noise ratio ...

Phil Nadeau, an analyst from TD Cowen, maintained the Buy rating on Vertex Pharmaceuticals (VRTX – Research Report). The associated price ...

Chinese module manufacturer Trina Solar has achieved a 25.9% cell efficiency for a bifacial i-TOPCON solar cell.

In its upcoming report, Vertex Pharmaceuticals (VRTX ... trends in earnings estimate revisions and the short-term price performance of a stock. While investors typically use consensus earnings ...

Trinasolar has recently reached a significant milestone, delivering more than 1 GW of its Vertex N 720W series modules to the ...

Vertex Pharmaceuticals again raised its full-year outlook after posting earnings and revenue growth in the third quarter. The biotechnology company on Monday posted a quarterly net profit of $1.05 ...

Reports Q3 revenue $2.77B, consensus $2.72B. “The third quarter marked another period of strong progress, with continued revenue growth ...

Vertex also reported a steady increase in its R&D and SG&A expenses, reflecting its aggressive investment in pipeline ...

If we use assume a 5-year timeline until Vertex reaches this figure, which, I believe, is reasonable given past performance and growth, that represents a CAGR of 6.83%, as seen in the calculations ...

This robust design ensures the longevity of modules, enabling stable performance even in harsh environmental conditions. Innovative encapsulation technology for diverse applications The Vertex S+ ...

Earnings per Share (EPS): Vertex's EPS is below the industry average, signaling challenges in bottom-line performance with a current EPS of 0.03. Debt Management: With a high debt-to-equity ratio ...

“With this key asset shift safely executed, our focus continues on further optimization of the business in pursuit of sustained performance and longer-term growth.” Vertex said the conversion ...